ID
45420
Beskrivning
Principal Investigator: Alison P. Klein, Johns Hopkins School of Medicine, Baltimore MD, USA MeSH: Pancreatic Neoplasms https://www.ncbi.nlm.nih.gov/projects/gap/cgi-bin/study.cgi?study_id=phs000648 Pancreatic cancer is the 4th leading cause of cancer death in the United States. This is in large part due to the rapidly fatal course of this disease, as the vast majority of patients die within months of diagnosis and the five-year survival rate is less than 5. We have brought together over 8000 participants from 9 studies of pancreatic cancer, to conduct a GWAS of pancreatic cancer. The studies were drawn from the Pancreatic Cancer Case-Control consortium and include case-control studies from the United States, Europe and Australia. Sites include: Johns Hopkins National Familial Pancreas Tumor Registry, Mayo Clinic Biospecimen Resource for Pancreas Research, Ontario Pancreas Cancer Study (OPCS), Yale University, MD Anderson Case Control Study, Queensland Pancreatic Cancer Study, University of California San Francisco Molecular Epidemiology of Pancreatic Cancer Study, International Agency of Cancer Research and Memorial Sloan Kettering Cancer Center
Länk
Nyckelord
Versioner (1)
- 2022-11-25 2022-11-25 - Chiara Middel
Rättsinnehavare
Alison P. Klein, Johns Hopkins School of Medicine, Baltimore MD, USA
Uppladdad den
25 november 2022
DOI
För en begäran logga in.
Licens
Creative Commons BY 4.0
Modellkommentarer :
Här kan du kommentera modellen. Med hjälp av pratbubblor i Item-grupperna och Item kan du lägga in specifika kommentarer.
Itemgroup-kommentar för :
Item-kommentar för :
Du måste vara inloggad för att kunna ladda ner formulär. Var vänlig logga in eller registrera dig utan kostnad.
dbGaP phs000648 Pancreatic Cancer Case-Control Association Study
Sample ID, body site where sample was collected, analyte type, histologic type, and tumor status of sample obtained from participants with or without pancreatic cancer and involved in the "Pancreatic Cancer Case Control Association Study" project.
- StudyEvent: SEV1
- Eligibility Criteria
- Subject ID, consent group, subject source, and source subject ID of participants with or without pancreatic cancer and involved in the "Pancreatic Cancer Case Control Association Study" project.
- Subject ID, sample ID, sample source, source sample ID, and sample use variable obtained from participants with or without pancreatic cancer and involved in the "Pancreatic Cancer Case Control Association Study" project.
- Subject ID, case or control, age, and race of participants with or without pancreatic cancer and involved in the "Pancreatic Cancer Case Control Association Study" project.
- Sample ID, body site where sample was collected, analyte type, histologic type, and tumor status of sample obtained from participants with or without pancreatic cancer and involved in the "Pancreatic Cancer Case Control Association Study" project.
Similar models
Sample ID, body site where sample was collected, analyte type, histologic type, and tumor status of sample obtained from participants with or without pancreatic cancer and involved in the "Pancreatic Cancer Case Control Association Study" project.
- StudyEvent: SEV1
- Eligibility Criteria
- Subject ID, consent group, subject source, and source subject ID of participants with or without pancreatic cancer and involved in the "Pancreatic Cancer Case Control Association Study" project.
- Subject ID, sample ID, sample source, source sample ID, and sample use variable obtained from participants with or without pancreatic cancer and involved in the "Pancreatic Cancer Case Control Association Study" project.
- Subject ID, case or control, age, and race of participants with or without pancreatic cancer and involved in the "Pancreatic Cancer Case Control Association Study" project.
- Sample ID, body site where sample was collected, analyte type, histologic type, and tumor status of sample obtained from participants with or without pancreatic cancer and involved in the "Pancreatic Cancer Case Control Association Study" project.
C1299222 (UMLS CUI [1,2])